No black box warning on record for Ninlaro

As of the latest FDA labeling reviewed, Ninlaro (IXAZOMIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ninlaro medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombocytopenia : Monitor platelet counts at least monthly during treatment and adjust dosing, as needed. ( 2.2 , 5.1 ) Gastrointestinal Toxicities : Adjust dosing for severe diarrhea, constipation, nausea, and vomiting, as needed. ( 2.2 , 5.2 ) Peripheral Neuropathy : Monitor patients for symptoms of peripheral neuropathy and adjust dosing, as needed. ( 2.2 , 5.3 ) Per

No black box warning on record for Ninlaro

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombocytopenia : Monitor platelet counts at least monthly during treatment and adjust dosing, as needed. ( 2.2 , 5.1 ) Gastrointestinal Toxicities : Adjust dosing for severe diarrhea, constipation, nausea, and vomiting, as needed. ( 2.2 , 5.2 ) Peripheral Neuropathy : Monitor patients for symptoms of peripheral neuropathy and adjust dosing, as needed. ( 2.2 , 5.3 ) Per

Ninlaro Black Box Warning

No black box warning on record for Ninlaro

Other warnings & precautions

Ninlaro Black Box Warning

No black box warning on record for Ninlaro

Other warnings & precautions